Selective mRNA translation determines adaptative mutability of melanoma cells to anti-BRAF/MEK combination therapy
Lucilla Fabbri, Lucie Lagadec, Eva Guérin…·Stéphan Vagner
This study shows that translational control of 53BP1 mRNA regulates adaptive mutability in melanoma cells, and targeting eIF4A reduces resistance to BRAF/MEK inhibitors.